Search Results - "Carlsten, M."

Refine Results
  1. 1

    The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies by Dosani, T, Carlsten, M, Maric, I, Landgren, O

    Published in Blood cancer journal (New York) (01-04-2015)
    “…As vast strides are being made in the management and treatment of multiple myeloma (MM), recent interests are increasingly focusing on understanding the…”
    Get full text
    Journal Article
  2. 2

    DIRECT PARENCHYMAL DELIVERY TO ANY ORGAN OR TUMOR VIA NEXT GENERATION ENDOVASCULAR TECHNIQUE – MINIMALLY INVASIVE AND EFFICIENT METHOD FOR TARGETED CELL AND GENE THERAPY by Al-Saadi, J., Waldén, M., Sohlmér, J., Grankvist, R., Friberger, I., Andersson, A., Lövljung, V., Settergren, M., Carlsten, M., Chien, K., Lundberg, J., Witman, N., Holmin, S.

    Published in CYTOTHERAPY (01-06-2024)
    “…A fundamental problem for cell/gene/drug delivery is to achieve right location, concentration and time. More specifically, the successful development of cell…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Coordinated expression of DNAM-1 and LFA-1 in educated NK cells by Enqvist, Monika, Ask, Eivind Heggernes, Forslund, Elin, Carlsten, Mattias, Abrahamsen, Greger, Béziat, Vivien, Andersson, Sandra, Schaffer, Marie, Spurkland, Anne, Bryceson, Yenan, Önfelt, Björn, Malmberg, Karl-Johan

    Published in The Journal of immunology (1950) (01-05-2015)
    “…The functional capacity of NK cells is dynamically tuned by integrated signals from inhibitory and activating cell surface receptors in a process termed NK…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34 blasts in myelodysplastic syndrome by Carlsten, M, Baumann, B C, Simonsson, M, Jädersten, M, Forsblom, A-M, Hammarstedt, C, Bryceson, Y T, Ljunggren, H-G, Hellström-Lindberg, E, Malmberg, K-J

    Published in Leukemia (01-09-2010)
    “…Myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal stem-cell disorders characterized by ineffective hematopoiesis and risk of progression…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells by Carlsten, Mattias, Järås, Marcus

    Published in Frontiers in immunology (11-10-2019)
    “…Natural killer (NK) cells are large granular lymphocytes involved in our defense against certain virus-infected and malignant cells. In contrast to T cells, NK…”
    Get full text
    Journal Article
  8. 8

    Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow by Sanz-Ortega, Laura, Andersson, Agneta, Carlsten, Mattias

    Published in Leukemia (01-03-2024)
    “…Increased bone marrow (BM) homing of NK cells is associated with positive outcome in patients with acute myeloid leukemia (AML) treated within adoptive NK cell…”
    Get full text
    Journal Article
  9. 9

    Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer by Daly, John, Carlsten, Mattias, O'Dwyer, Michael

    Published in Frontiers in immunology (2019)
    “…Natural Killer (NK) cells are cytotoxic lymphocytes that play a key role in the immune system, targeting and destroying invading pathogens and malignantly…”
    Get full text
    Journal Article
  10. 10

    Natural killer cell-mediated immunosurveillance of human cancer by Malmberg, Karl-Johan, Carlsten, Mattias, Björklund, Andreas, Sohlberg, Ebba, Bryceson, Yenan T., Ljunggren, Hans-Gustaf

    Published in Seminars in immunology (01-06-2017)
    “…The contribution of natural killer (NK) cells to immunosurveillance of human cancer remains debatable. Here, we discuss advances in several areas of human NK…”
    Get full text
    Journal Article
  11. 11

    Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy by Gaggero, Silvia, Witt, Kristina, Carlsten, Mattias, Mitra, Suman

    Published in Frontiers in immunology (29-01-2021)
    “…Natural killer (NK) cells are endowed with germline-encoded receptors that enable them to detect and kill malignant cells without prior priming. Over the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4R334X by Levy, Emily, Reger, Robert, Segerberg, Filip, Lambert, Melanie, Leijonhufvud, Caroline, Baumer, Yvonne, Carlsten, Mattias, Childs, Richard

    Published in Frontiers in immunology (05-06-2019)
    “…Adoptive transfer of natural killer (NK) cells can induce remission in patients with relapsed/refractory leukemia and myeloma. However, to date, clinical…”
    Get full text
    Journal Article
  16. 16

    Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells by Palau, Anna, Segerberg, Filip, Lidschreiber, Michael, Lidschreiber, Katja, Naughton, Aonghus J., Needhamsen, Maria, Jung, Lisa Anna, Jagodic, Maja, Cramer, Patrick, Lehmann, Sören, Carlsten, Mattias, Lennartsson, Andreas

    Published in Leukemia (2023)
    “…Isocitrate dehydrogenase (IDH) mutations are found in 20% of acute myeloid leukemia (AML) patients. However, only 30–40% of the patients respond to IDH…”
    Get full text
    Journal Article
  17. 17

    Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells by Carlsten, Mattias, Norell, Hakan, Bryceson, Yenan T, Poschke, Isabel, Schedvins, Kjell, Ljunggren, Hans-Gustaf, Kiessling, Rolf, Malmberg, Karl-Johan

    Published in The Journal of immunology (1950) (15-10-2009)
    “…The activating NK cell receptor DNAX accessory molecule-1 (DNAM-1) contributes to tumor immune surveillance and plays a crucial role in NK cell-mediated…”
    Get full text
    Journal Article
  18. 18

    CRISPR/Cas9-Based Gene Engineering of Human Natural Killer Cells: Protocols for Knockout and Readouts to Evaluate Their Efficacy by Lambert, Mélanie, Leijonhufvud, Caroline, Segerberg, Filip, Melenhorst, J Joseph, Carlsten, Mattias

    “…Natural killer (NK) cells are cytotoxic lymphocytes of our immune system with the ability to identify and kill certain virally infected and tumor-transformed…”
    Get more information
    Journal Article
  19. 19

    The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome by Noring, Kristina, Carlsten, Mattias, Sonnevi, Kristina, Wahlin, Björn Engelbrekt

    Published in BMC cancer (04-05-2021)
    “…Chimeric antigen-receptor T-cell and bispecific antibody therapies will likely necessitate a reconsideration of the role of autologous stem-cell…”
    Get full text
    Journal Article
  20. 20

    Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up by Hagström, Hannes, Andreasson, Anna, Carlsson, Axel C, Jerkeman, Mats, Carlsten, Mattias

    Published in PloS one (23-08-2018)
    “…High body mass index (BMI) is associated with development of hematological malignancies (HMs). However, although BMI is a well-established measurement of…”
    Get full text
    Journal Article